Page last updated: 2024-11-05

5-methylurapidil and Adenoma, Prostatic

5-methylurapidil has been researched along with Adenoma, Prostatic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kenny, B1
Ballard, S1
Blagg, J1
Fox, D1
Elworthy, TR1
Ford, AP1
Bantle, GW1
Morgans, DJ1
Ozer, RS1
Palmer, WS1
Repke, DB1
Romero, M1
Sandoval, L1
Sjogren, EB1
Talamás, FX1
Vazquez, A1
Wu, H1
Arredondo, NF1
Blue, DR1
DeSousa, A1
Gross, LM1
Kava, MS1
Lesnick, JD1
Vimont, RL1
Williams, TJ1
Zhu, QM1
Pfister, JR1
Clarke, DE1

Reviews

1 review available for 5-methylurapidil and Adenoma, Prostatic

ArticleYear
Pharmacological options in the treatment of benign prostatic hyperplasia.
    Journal of medicinal chemistry, 1997, Apr-25, Volume: 40, Issue:9

    Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlle

1997

Other Studies

1 other study available for 5-methylurapidil and Adenoma, Prostatic

ArticleYear
N-arylpiperazinyl-N'-propylamino derivatives of heteroaryl amides as functional uroselective alpha 1-adrenoceptor antagonists.
    Journal of medicinal chemistry, 1997, Aug-15, Volume: 40, Issue:17

    Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Aged; Amid

1997